>
Mach7 Technologies logo

M7T - Mach7 Technologies Share Price

A$1.07 0.0  0.5%

Last Trade - 5:45am

Sector
Healthcare
Size
Small Cap
Market Cap £136.8m
Enterprise Value £129.5m
Revenue £9.28m
Position in Universe 570th / 1912
Bullish
Bearish
Unlock M7T Revenue
Momentum
Relative Strength (%)
1m -21.5%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -33.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.17 1.86 10.3 8.64 9.35 18.9 22.8 28.7 +157.4%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2020, Mach7Technologies Ltd revenues decreased 22% to A$7.1M. Net losstotaled A$7.2M vs. income of A$675K. Revenues reflectEnterprise imaging data platform segment decrease of 48% toA$4.5M, United States segment decrease of 15% to A$5.9M,Asia/Pacific segment decrease of 60% to A$616K. Net lossreflects Depreciation and amortisation increase from A$1.9Mto A$5.1M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

M7T Revenue Unlock M7T Revenue

Net Income

M7T Net Income Unlock M7T Revenue

Normalised EPS

M7T Normalised EPS Unlock M7T Revenue

PE Ratio Range

M7T PE Ratio Range Unlock M7T Revenue

Dividend Yield Range

M7T Dividend Yield Range Unlock M7T Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
M7T EPS Forecasts Unlock M7T Revenue
Profile Summary

Mach7 Technologies Limited is a provider of medical imaging software and services for healthcare institutions, predominantly throughout the United States, Asia-pacific, and the Middle East region. Its enterprise imaging platform provides a vendor neutral foundation for unstructured data consolidation and communication to power interoperability and enables healthcare enterprises to build their clinical ecosystems. It operates through two segments: sale of software licenses, and provision of professional services such as implementation & training, data migration, support and maintenance services. Its core product, the Mach7 Platform provides the robust and functional healthcare information technology (IT) platform in the industry for clinical archiving and communication. The platform consists of vendor neutral archive, migration, communication work engine, quality control, patient and clinical portal, patient and order management, and mobile image capture.

Directors
Last Annual June 30th, 2020
Last Interim December 31st, 2020
Incorporated January 20, 1977
Public Since November 30, 2005
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P/ASX All Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 234,717,716
Free Float (0.0%)
Eligible for
ISAs
SIPPs
M7T Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for M7T
Upcoming Events for M7T
Frequently Asked Questions for Mach7 Technologies
What is the Mach7 Technologies share price?

As of 5:45am, shares in Mach7 Technologies are trading at A$1.07, giving the company a market capitalisation of £136.8m. This share price information is delayed by 15 minutes.

How has the Mach7 Technologies share price performed this year?

Shares in Mach7 Technologies are currently trading at A$1.07 and the price has moved by 89.62% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Mach7 Technologies price has moved by 45.03% over the past year.

What are the analyst and broker recommendations for Mach7 Technologies?

There are no analysts currently covering Mach7 Technologies.

When will Mach7 Technologies next release its financial results?

Mach7 Technologies is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Mach7 Technologies dividend yield?

Mach7 Technologies does not currently pay a dividend.

Does Mach7 Technologies pay a dividend?

Mach7 Technologies does not currently pay a dividend.

When does Mach7 Technologies next pay dividends?

Mach7 Technologies does not currently pay a dividend.

How do I buy Mach7 Technologies shares?

To buy shares in Mach7 Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Mach7 Technologies?

Shares in Mach7 Technologies are currently trading at A$1.07, giving the company a market capitalisation of £136.8m.

Where are Mach7 Technologies shares listed? Where are Mach7 Technologies shares listed?

Here are the trading details for Mach7 Technologies:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: M7T
What kind of share is Mach7 Technologies?

Based on an overall assessment of its quality, value and momentum, Mach7 Technologies is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Mach7 Technologies share price forecast 2021?

Shares in Mach7 Technologies are currently priced at A$1.07. At that level they are trading at 58.49% discount to the analyst consensus target price of 0.00.

Analysts covering Mach7 Technologies currently have a consensus Earnings Per Share (EPS) forecast of -0.028 for the next financial year.

How can I tell whether the Mach7 Technologies share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mach7 Technologies. Over the past six months, the relative strength of its shares against the market has been -12.99%. At the current price of A$1.07, shares in Mach7 Technologies are trading at -10.42% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Mach7 Technologies PE Ratio?

We were not able to find PE ratio data for Mach7 Technologies.

Who are the key directors of Mach7 Technologies?

Mach7 Technologies's management team is headed by:

Jenni Pilcher - CFO
Alister Spittle - NED
Mike Lampron - CEO
Eliot Siegel - NED
David Chambers - NEC
Robert Bazzani - NED
Philippe Houssiau - NED
Who are the major shareholders of Mach7 Technologies?

Here are the top five shareholders of Mach7 Technologies based on the size of their shareholding:

JM Financial Group Ltd. Corporation
Percentage owned: 11.14% (26.2m shares)
Clime Investment Management Ltd Corporation
Percentage owned: 8.08% (19.0m shares)
Australian Ethical Investment Ltd. Investment Advisor
Percentage owned: 6.43% (15.1m shares)
Krishnan (Ravindran) Individual Investor
Percentage owned: 2.05% (4.83m shares)
PT Dwi Satrya Utama Corporation
Percentage owned: 1.86% (4.39m shares)
Similar to M7T
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.